In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum. Application of 2081-44-9, Application of 2081-44-9, C5H10O2. A document type is Patent, introducing its new discovery.
FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.
We very much hope you enjoy reading the articles and that you will join us to present your own research about 2081-44-9, Application of 2081-44-9
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics